Company Reports 50% Increase in Revenue 3SBio (SSRX), the Shenyang biotech that made its US IPO in February, released its second quarter financial report, showing the company greatly increased both revenues and earnings. The company said its revenues jumped 49% over the year-earlier quarter to 43.1 million RMB ($5.7 million), and earnings were up 70% to 13.8 million RMB ($1.8 million). That works out to an earnings-per-ADS of 14 cents. More details...